Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

key pharmaceuticals ltd - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

United States - English - NLM (National Library of Medicine)

orient pharma co., ltd. - ezetimibe (unii: eor26lqq24) (ezetimibe - unii:eor26lqq24) - ezetimibe tablet is indicated: - in combination with a statin, or alone when additional low-density lipoprotein cholesterol (ldl-c) lowering therapy is not possible, as an adjunct to diet to reduce elevated ldl-c in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (hefh). - in combination with a statin as an adjunct to diet to reduce elevated ldl-c in pediatric patients 10 years of age and older with hefh. - in combination with fenofibrate as an adjunct to diet to reduce elevated ldl-c in adults with mixed hyperlipidemia. - in combination with a statin, and other ldl-c lowering therapies, to reduce elevated ldl-c levels in adults and in pediatric patients 10 years of age and older with homozygous familial hypercholesterolemia (hofh). - as an adjunct to diet for the reduction of elevated sitosterol and campesterol levels in adults and in pediatric patients 9 years of age and older with homozygous familial sitosterolemia. when ezetimibe tablet is used in combination with

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ezetimibe; simvastatin - tablet - 10 mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe